ImmunityBio, Inc.

Historical 13F Holders

Symbol
IBRX
CUSIP
45256X103
All holders as of
Q2 2026
Type
Equity
Class
COM
Reported Value, Excluding Options
Total Shares Held, Excluding Options
Total Filers

13D/G Filers

Every filing for 45256X103 since 12/18/2024, newest first.

Filer % of Class Filed
Cambridge Equities, LP 13D/A Amendment 13
64.8% 8/6/2026
Event 7/31/2026
Cambridge Equities, LP 13D/A Amendment 12
66.3% 2/25/2026
Event 2/23/2026
Cambridge Equities, LP 13D/A Amendment 11
68.9% 11/10/2025
Event 11/10/2025

13F Holders by Quarter

Period Filers Shares, Excl. Options Value, Excl. Options
2026 Q3 193 30.2 M $284M
2026 Q2 413 206 M $2.19B
2026 Q1 395 179 M $1.37B
2025 Q4 279 170 M $339M
2025 Q3 264 151 M $371M
2025 Q2 244 125 M $331M
2025 Q1 216 79.6 M $240M
2024 Q4 206 82.7 M $212M
2024 Q3 185 69.8 M $259M
2024 Q2 199 63.6 M $402M
2024 Q1 173 69.1 M $371M
2023 Q4 152 60.8 M $305M
2023 Q3 136 49.9 M $84.1M
2023 Q2 122 39.1 M $109M
2023 Q1 150 46.2 M $89.2M
2022 Q4 145 56.8 M $290M
2022 Q3 130 39.5 M $197M
2022 Q2 136 33.1 M $125M
2022 Q1 152 35.7 M $200M
2021 Q4 144 35.4 M $215M
2021 Q3 124 31.9 M $311M
2021 Q2 124 27.8 M $390M
2021 Q1 119 16.0 M $379M
2020 Q4 1 100 $1.00k
2020 Q3 1 100 $1.00k
2020 Q2 1 100 $1.00k
2020 Q1 1 100 $1.00k
2019 Q4 1 100 $1.00k
2019 Q3 1 100 $1.00k
2019 Q2 1 100 $1.00k
2019 Q1 1 100 $1.00k